Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 592-594. doi: 10.19723/j.issn.1671-167X.2022.04.002

Previous Articles     Next Articles

崔建 张*(),志嵩 何,利群 周   

  • Received:2022-04-07 Online:2022-08-18 Published:2022-08-11
  • Contact: 崔建 张 E-mail:surgeon_zhang@126.com

RICH HTML

  

CLC Number: 

  • R737.1
1 Roupret M , Babjuk M , Burger M , et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update[J]. Eur Urol, 2021, 79 (1): 62- 79.
doi: 10.1016/j.eururo.2020.05.042
2 Siegel RL , Miller KD , Fuchs HE , et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71 (1): 7- 33.
doi: 10.3322/caac.21654
3 Nortier JL , Martinez MCM , Schmeiser HH , et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)[J]. New Engl J Med, 2000, 342 (23): 1686- 1692.
doi: 10.1056/NEJM200006083422301
4 Huang PC , Huang CY , Huang SW , et al. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan[J]. Int J Urol, 2006, 13 (7): 864- 869.
doi: 10.1111/j.1442-2042.2006.01429.x
5 Karl A , Carroll PR , Gschwend JE , et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer[J]. Eur Urol, 2009, 55 (4): 826- 835.
doi: 10.1016/j.eururo.2009.01.004
6 Mason RJ , Kassouf W , Bell DG , et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: The Canadian experience[J]. Urology, 2012, 79 (4): 840- 845.
doi: 10.1016/j.urology.2011.11.058
7 Roscigno M , Brausi M , Heidenreich A , et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer[J]. Eur Urol, 2011, 60 (4): 776- 783.
doi: 10.1016/j.eururo.2011.07.009
8 Dorfman RE , Alpern MB , Gross BH , et al. Upper abdominal lymph nodes: criteria for normal size determined with CT[J]. Radiology, 1991, 180 (2): 319- 322.
doi: 10.1148/radiology.180.2.2068292
9 Voskuilen CS , Schweitzer D , Jensen JB , et al. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma[J]. Eur Urol Oncol, 2020, 3 (1): 73- 79.
doi: 10.1016/j.euo.2019.09.004
10 Kondo T , Nakazawa H , Ito F , et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract[J]. Urology, 2007, 69 (2): 265- 269.
doi: 10.1016/j.urology.2006.10.014
11 Kondo T , Tanabe K . Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract[J]. Int J Urol, 2012, 19 (8): 710- 721.
doi: 10.1111/j.1442-2042.2012.03009.x
12 Matin SF , Sfakianos JP , Espiritu PN , et al. Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates[J]. J Urol, 2015, 194 (6): 1567- 1574.
doi: 10.1016/j.juro.2015.06.077
13 Roscigno M , Cozzarini C , Bertini R , et al. Prognostic value of lymph node dissection in patients with muscleinvasive transitional cell carcinoma of the upper urinary tract[J]. Eur Urol, 2008, 53 (4): 794- 802.
doi: 10.1016/j.eururo.2008.01.008
14 Secin FP , Koppie TM , Salamanca JI , et al. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer[J]. Int J Urol, 2007, 14 (1): 26- 32.
doi: 10.1111/j.1442-2042.2006.01664.x
15 Gschwend JE , Heck MM , Lehmann J , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: Survival results from a prospective, randomized trial[J]. Eur Urol, 2019, 75 (4): 604- 611.
doi: 10.1016/j.eururo.2018.09.047
16 Ouzzane A , Colin P , Ghoneim TP , et al. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy[J]. World J Urol, 2013, 31 (1): 189- 197.
doi: 10.1007/s00345-012-0983-1
17 Burger M , Shariat SF , Fritsche HM , et al. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: A retrospective international, multi-institutional study[J]. World J Urol, 2011, 29 (4): 465- 472.
doi: 10.1007/s00345-011-0705-0
18 Roscigno M , Shariat SF , Margulis V , et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy[J]. J Urol, 2009, 181 (6): 2482- 2489.
doi: 10.1016/j.juro.2009.02.021
19 Lughezzani G , Jeldres C , Isbarn H , et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma[J]. Urology, 2010, 75 (1): 118- 124.
doi: 10.1016/j.urology.2009.07.1296
20 Roscigno M , Shariat SF , Freschi M , et al. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer[J]. Urology, 2009, 74 (5): 1070- 1074.
doi: 10.1016/j.urology.2009.04.084
21 Brausi MA , Gavioli M , De Luca G , et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: Impact on survival[J]. Eur Urol, 2007, 52 (5): 1414- 1418.
doi: 10.1016/j.eururo.2007.04.070
22 Kondo T , Hara I , Takagi T , et al. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study[J]. Int J Urol, 2014, 21 (5): 453- 459.
doi: 10.1111/iju.12338
23 Cho KS , Choi HM , Koo K , et al. Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy[J]. J Korean Med Sci, 2009, 24 (4): 674- 678.
doi: 10.3346/jkms.2009.24.4.674
24 Miyake H , Hara I , Gohji K , et al. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract[J]. Br J Urol, 1998, 82 (4): 494- 498.
doi: 10.1046/j.1464-410X.1998.00800.x
25 Kondo T , Nakazawa H , Ito F , et al. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract[J]. J Urol, 2007, 178 (4 Pt 1): 1212- 1217.
26 Rao SR , Correa JJ , Sexton WJ , et al. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma[J]. BJU Int, 2012, 110 (11 pt B): E475- E480.
27 Abe T , Takada N , Matsumoto R , et al. Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: A prospective study[J]. J Endourol, 2015, 29 (3): 304- 309.
doi: 10.1089/end.2014.0369
[1] Haoming YIN, Zijie WANG, Fan SHU, Zhanyi ZHANG, Hui LIANG, Shudong ZHANG. Expression and significance of the FABP6 long transcript in clear cell renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 393-398.
[2] Shenmo LI, Dandan SU, Jiyu LIN, Haodong SONG, Lulin MA, Xiaofei HOU, Guoliang WANG, Hongxian ZHANG, Jianfei YE, Shudong ZHANG. Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 961-966.
[3] Boda GUO, Min LU, Guoliang WANG, Hongxian ZHANG, Lei LIU, Xiaofei HOU, Lei ZHAO, Xiaojun TIAN, Shudong ZHANG. Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 644-649.
[4] Zhanyi ZHANG, Min LU, Yuehao SUN, Jinghan DONG, Xiaofei HOU, Chunlei XIAO, Guoliang WANG, Xiaojun TIAN, Lulin MA, Hongxian ZHANG, Shudong ZHANG. Clinicopathological features and survival analysis of TFE3-rearranged renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 650-661.
[5] Qi MIAO, Baoan HONG, Xuezhou ZHANG, Zhipeng SUN, Wei WANG, Yuxuan WANG, Yuxuan BO, Jiahui ZHAO, Ning ZHANG. Risk assessment of perioperative adverse events and management of antiplatelet therapy in patients with bladder cancer and coronary atherosclerotic heart disease undergoing transurethral resection of bladder cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 698-703.
[6] Zezhen ZHOU, Liyuan GE, Fan ZHANG, Shaohui DENG, Ye YAN, Hongxian ZHANG, Guoliang WANG, Lei LIU, Yi HUANG, Shudong ZHANG. A retrospective matching study of partial nephrectomy and radical nephrectomy for pathological T3a stage renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 704-710.
[7] Shuai LIU, Zhuo LIU, Yunhe GUAN, Guoliang WANG, Xiaojun TIAN, Hongxian ZHANG, Lei LIU, Lulin MA, Shudong ZHANG. Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 796-802.
[8] Zezhen ZHOU,Shaohui DENG,Ye YAN,Fan ZHANG,Yichang HAO,Liyuan GE,Hongxian ZHANG,Guoliang WANG,Shudong ZHANG. Predicting the 3-year tumor-specific survival in patients with T3a non-metastatic renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 673-679.
[9] Binshuai WANG,Min QIU,Qianjin ZHANG,Maofeng TIAN,Lei LIU,Guoliang WANG,Min LU,Xiaojun TIAN,Shudong ZHANG. Experience in diagnosis and treatment of 6 cases of renal Ewing's sarcoma with venous thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 636-639.
[10] Jie YANG,Jieli FENG,Shudong ZHANG,Lulin MA,Qing ZHENG. Clinical effects of transesophageal echocardiography in different surgical methods for nephrectomy combined with Mayo Ⅲ-Ⅳ vena tumor thrombectomy [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 631-635.
[11] Kewei CHEN,Zhuo LIU,Shaohui DENG,Fan ZHANG,Jianfei YE,Guoliang WANG,Shudong ZHANG. Clinical diagnosis and treatment of renal angiomyolipoma with inferior vena cava tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 617-623.
[12] Le YU,Shaohui DENG,Fan ZHANG,Ye YAN,Jianfei YE,Shudong ZHANG. Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 661-666.
[13] Fan SHU,Yichang HAO,Zhanyi ZHANG,Shaohui DENG,Hongxian ZHANG,Lei LIU,Guoliang WANG,Xiaojun TIAN,Lei ZHAO,Lulin MA,Shudong ZHANG. Functional and oncologic outcomes of partial nephrectomy for cystic renal cell carcinoma: A single-center retrospective study [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 667-672.
[14] 树栋 张,睿扬 谢. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 562-564.
[15] Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!